Connect with us

Medical Discovery

Hans Rosling: Debunking third-world myths with the best stats you’ve ever seen

Published

on



You’ve never seen data presented like this. With the drama and urgency of a sportscaster, statistics guru Hans Rosling debunks myths about the so-called “developing world.”

TEDTalks is a daily video podcast of the best talks and performances from the TED Conference, where the world’s leading thinkers and doers are invited to give the talk of their lives in 18 minutes — including speakers such as Jill Bolte Taylor, Sir Ken Robinson, Hans Rosling, Al Gore and Arthur Benjamin. TED stands for Technology, Entertainment, and Design, and TEDTalks cover these topics as well as science, business, politics and the arts. Watch the Top 10 TEDTalks on TED.com, at

Continue Reading
26 Comments

26 Comments

  1. X-01 Unknown

    February 5, 2018 at 7:26 pm

    Ok for those just now tuning in. This data represents “life expectancy” of the LIVING. It does not represent population drops due to tyranny or disasters. It measured factors that affect every single person. So if you died via gunshot wound at the age of 20, then you are NOT represented in this data. It’s pointless to taint the data with irrelevant information. This info is compiled so that we can see the correlations between wealth, education, food supply, etc… and how lack thereof affects the duration of the average life span over the decades.

  2. Brad Smith

    February 6, 2018 at 12:45 am

    9:16 – HAHAHAHA. When you remove the Arabs from Africa, Africa goes backwards. As a white South African, I know why that is. LOLZ.

  3. Brad Smith

    February 6, 2018 at 1:01 am

    Can we have one on IQ please? That will explain everything you've seen here.

  4. xdygmnyrdf

    February 6, 2018 at 8:28 pm

    woooooow a youtube video from 2007

  5. Rhona Ann Proxenos

    February 10, 2018 at 5:17 am

    Well this debunks every conspiracy theory of how bad governments are..

  6. Avadhoot Shejwalkar

    February 11, 2018 at 5:47 pm

    Awesome!

  7. Daniel

    February 15, 2018 at 7:04 pm

    It's been a fucking decade since this video. I would love to tihis chart from 2003-2013

  8. Balázs Huszár

    February 17, 2018 at 12:44 am

    eh?…. Eh!

  9. Simon Sozzi

    February 17, 2018 at 6:28 am

    Such a great speaker he was

  10. Misan7hrope

    February 18, 2018 at 12:28 pm

    Awesome dude, rest in peace!

  11. Filip musiatowicz

    February 19, 2018 at 9:05 am

    so bad this brilliant mind has gone …rip professor

  12. Cortana D.

    February 19, 2018 at 2:25 pm

    OH! I just go to this site and find why this flash seems so familiar to me: I have used that stat visualizing tool once!
    It was just awesome! Thanks!

  13. MajkaSrajka

    February 19, 2018 at 10:10 pm

    1.8 students, 2.4 professors on child mortality?
    Daymn, all of these are super logical, and getting less than two?

    South Korea and Thailand are EZ – SK is basically Japan 2.0. Similar thing with Malaysia/Russia.
    The only two pretty tough one are Turkey vs Sri Lanka and Thailand vs South Africa, but again you can pretty easily bet new world / asians master race over old world.

  14. BILGILI KANAL

    February 21, 2018 at 6:11 pm

    inclusivenes is important most developing countrie dont let people go where their skills take them

  15. Zeet

    February 21, 2018 at 7:49 pm

    It's NOT a completely new world though… are you blind? All of Africa is still at the lower right corner? Wtf is this guy talking about, he's flat out lying.

  16. kingogkingswoodz

    February 23, 2018 at 2:05 am

    Cuba numbers come from a corrupt closed government and their false.

  17. Yididiya Mulatu

    February 23, 2018 at 12:39 pm

    haha, love this guy

  18. smokeyjayshouse

    February 23, 2018 at 5:07 pm

    Mao Zedong murdered anyone who he didn't like or looked at him funny. The guy is known for killing 70 million people in his own country according to their own documents. He was no health hero in China

  19. Suh Cars

    February 25, 2018 at 9:12 pm

    White population is falling, so Africa will stop getting helped by white people, so their population will also fall.

  20. Bruno Gomes

    February 26, 2018 at 2:58 pm

    So are you sterilising Africans after their 2nd child or what's the plan?
    We know the causes, you need real solutions

  21. Sunshine Starcraft

    February 27, 2018 at 2:46 pm

    Mao tse tong brought health to china ? W T F

  22. Fart Farmer 2.0

    February 28, 2018 at 1:44 pm

    R.I.P

  23. Giannova Ryandanny

    March 5, 2018 at 12:28 am

    Very nice knowledge, thank you. But i have question, if asian, arabic and other country can catch the western very fast, its mean the western grow very slow. Did it will reach point that every country have slower rate to grow ? Or the wester n will be passed by other countries ?

  24. Dämonischer Absurdismus

    March 5, 2018 at 7:48 am

    Well you put feminism in Sweden you shouldn't expect the outcome more than a chimpanzee!

  25. Jason Dashney

    March 5, 2018 at 5:45 pm

    I'm very wary of him using that $1/$10/$100 log scale. Very, very few people can "see" them for what they really are so it's deceptive to most people.

  26. Jay Edlington

    March 6, 2018 at 1:01 am

    Phenomenal. Just show kids this in class & be done with it. Forget social sensitivity training, just make them go to TED conferences like 3 times each semester…

Leave a Reply

Your email address will not be published. Required fields are marked *

Medical Discovery

IDZ Weekly | Deep Neural Network Acceleration for Image Analysis in Drug Discovery | Intel Software

Published

on

By



Learn about a recent collaboration with Novartis Pharmaceuticals, which utilizes a deep neural network to accelerate image analysis in early drug discovery by detecting and targeting exactly which cells in the body need treatment.

Read the article:

Keep up to date with the IDZ Weekly Youtube Playlist:

Subscribe to the Intel Software YouTube Channel:

About Intel Software:
The Intel® Developer Zone encourages and supports software developers that are developing applications for Intel hardware and software products. The Intel Software YouTube channel is a place to learn tips and tricks, get the latest news, watch product demos from both Intel, and our many partners across multiple fields. You’ll find videos covering the topics listed below, and to learn more, you can follow the links provided!

Connect with Intel Software:
Visit INTEL SOFTWARE WEBSITE:
Like INTEL SOFTWARE on FACEBOOK:
Follow INTEL SOFTWARE on TWITTER:

INTEL SOFTWARE GITHUB:
INTEL DEVELOPER ZONE LINKEDIN:
INTEL DEVELOPER ZONE INSTAGRAM:
INTEL GAME DEV TWITCH:

IDZ Weekly | Deep Neural Network Acceleration for Image Analysis in Drug Discovery | Intel Software

Continue Reading

Medical Discovery

Virtual Recap Preview: Stanford Drug Discovery Symposium 2018 – Joao Monteiro, MD, PhD

Published

on

By



Virtual Recap: Stanford Drug Discovery 2018
Learn more:

On April 23-24,2018 over 550 people gathered at the Li Ka Shing Conference Center to attend the Third Annual Stanford Drug Discovery Symposium. The event featured a broad range of speakers sharing their expertise in the fields of: academic drug discovery, academic-industry collaboration, science policy, publishing, and research funding. On the first day, the packed-house audience was treated to presentations from academic scientists engaged in groundbreaking research that is laying the foundation for future therapeutic approaches. These included Stanford based Nobel Laureate Brian Kobilka, MD and Edgar Engleman, MD; Kathleen Giacomini, PhD, and Kevan Shokat, PhD from UCSF; and Hugh Rosen, MD, PhD, from the Scripps Research Institute.

Later that afternoon, attendees had the rare opportunity to interact with six top pharmaceutical executives and philanthropists: Ken Frazier, CEO of Merck; Robert Bradway, CEO of Amgen; Joseph Jimenez, former CEO of Novartis; Brent Saunders, CEO of Allergan; Patrick Soon-Shiong, MD, CEO of Nantworks; and Sanford Weill, the Chairman Emeritus of Citigroup and CEO of Casa Rosa Ventures. In this “View from the Top” session moderated by Stanford President Marc Tessier-Lavigne, PhD, the panelists offered their perspectives on drug discovery, including: the future of personalized medicine, the importance of focusing on disease prevention rather than treatment, and the concept that drug pricing could eventually be based on treatment outcomes. The first day ended with the presentation of a Lifetime Achievement Award to Roy Vagelos, MD, former CEO of Merck and current Board chair of Regeneron. Dr. Vagelos was acknowledged in part for his role in leveraging the power of the pharmaceutical industry to make a major impact on global health. During his term as Merck CEO, he personally committed to providing the drug Ivermectin free of charge to anyone in the world for the treatment of elephantiasis and river blindness, with the latter having been since eradicated in multiple Central and South American countries due to Dr. Vagelos’ efforts.

The second day of the Symposium opened with a Keynote address from Janet Woodcock, MD, the Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), who provided a look inside the agency’s new drug regulatory program. This was followed by important presentations about funding priorities from Gary Gibbons, MD, the Director of the National Heart, Lung, and Blood Institute (NHLBI), and Maria Millan, MD, President and CEO of the California Institute for Regenerative Medicine (CIRM). Later, the audience was treated to a panel of editors representing the top publications in biomedical science: the New England Journal of Medicine, Nature Medicine, Science, and the Journal of the American Medical Association. The meeting concluded with a dynamic Shark Tank-style session, in which representatives from eight competitively selected start-up biotechnology companies pitched their ideas to a panel of scientists, venture capitalists, and CEOs. The panelists who provided feedback were: George Scangos, PhD (CEO of Vir), Robert Robbins, MD (President of the University of Arizona), Roy Vagelos, MD, Amy Chang, MSEE (CEO of Accompany), Ram Shriram (Founder of Sherpalo), and Wende Hutton, MBA (General Partner, Canaan). The goal of this session was to have this stellar panel identify strengths and weaknesses of the strategies described in each presentation, providing invaluable advice to these budding entrepreneurs.

The organizers of the meeting, Joseph Wu, MD, PhD; Sanjay Malhotra, PhD; Kuldev Singh, MD; Mark Mercola, PhD; and Chaitan Khosla, PhD, are thrilled with the success of this gathering, and are already looking forward to the next iteration, which will be held April 22-23, 2019.

___

Copyright Keystone Symposia, 2018. All rights reserved.

About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Visit Keystone Symposia at:

Visit Virtual Keystone Symposia at:

For more videos:

Follow us on Twitter:

Like us on Facebook:

Link to us on LinkedIn:

Outro music:
“Slider” by Blue Dot Sessions (

Continue Reading

Medical Discovery

Virtual Recap Preview: Stanford Drug Discovery Symposium 2018 – Janet Woodcock, MD

Published

on

By



Virtual Recap: Stanford Drug Discovery 2018
Learn more:

On April 23-24,2018 over 550 people gathered at the Li Ka Shing Conference Center to attend the Third Annual Stanford Drug Discovery Symposium. The event featured a broad range of speakers sharing their expertise in the fields of: academic drug discovery, academic-industry collaboration, science policy, publishing, and research funding. On the first day, the packed-house audience was treated to presentations from academic scientists engaged in groundbreaking research that is laying the foundation for future therapeutic approaches. These included Stanford based Nobel Laureate Brian Kobilka, MD and Edgar Engleman, MD; Kathleen Giacomini, PhD, and Kevan Shokat, PhD from UCSF; and Hugh Rosen, MD, PhD, from the Scripps Research Institute.

Later that afternoon, attendees had the rare opportunity to interact with six top pharmaceutical executives and philanthropists: Ken Frazier, CEO of Merck; Robert Bradway, CEO of Amgen; Joseph Jimenez, former CEO of Novartis; Brent Saunders, CEO of Allergan; Patrick Soon-Shiong, MD, CEO of Nantworks; and Sanford Weill, the Chairman Emeritus of Citigroup and CEO of Casa Rosa Ventures. In this “View from the Top” session moderated by Stanford President Marc Tessier-Lavigne, PhD, the panelists offered their perspectives on drug discovery, including: the future of personalized medicine, the importance of focusing on disease prevention rather than treatment, and the concept that drug pricing could eventually be based on treatment outcomes. The first day ended with the presentation of a Lifetime Achievement Award to Roy Vagelos, MD, former CEO of Merck and current Board chair of Regeneron. Dr. Vagelos was acknowledged in part for his role in leveraging the power of the pharmaceutical industry to make a major impact on global health. During his term as Merck CEO, he personally committed to providing the drug Ivermectin free of charge to anyone in the world for the treatment of elephantiasis and river blindness, with the latter having been since eradicated in multiple Central and South American countries due to Dr. Vagelos’ efforts.

The second day of the Symposium opened with a Keynote address from Janet Woodcock, MD, the Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), who provided a look inside the agency’s new drug regulatory program. This was followed by important presentations about funding priorities from Gary Gibbons, MD, the Director of the National Heart, Lung, and Blood Institute (NHLBI), and Maria Millan, MD, President and CEO of the California Institute for Regenerative Medicine (CIRM). Later, the audience was treated to a panel of editors representing the top publications in biomedical science: the New England Journal of Medicine, Nature Medicine, Science, and the Journal of the American Medical Association. The meeting concluded with a dynamic Shark Tank-style session, in which representatives from eight competitively selected start-up biotechnology companies pitched their ideas to a panel of scientists, venture capitalists, and CEOs. The panelists who provided feedback were: George Scangos, PhD (CEO of Vir), Robert Robbins, MD (President of the University of Arizona), Roy Vagelos, MD, Amy Chang, MSEE (CEO of Accompany), Ram Shriram (Founder of Sherpalo), and Wende Hutton, MBA (General Partner, Canaan). The goal of this session was to have this stellar panel identify strengths and weaknesses of the strategies described in each presentation, providing invaluable advice to these budding entrepreneurs.

The organizers of the meeting, Joseph Wu, MD, PhD; Sanjay Malhotra, PhD; Kuldev Singh, MD; Mark Mercola, PhD; and Chaitan Khosla, PhD, are thrilled with the success of this gathering, and are already looking forward to the next iteration, which will be held April 22-23, 2019.

___

Copyright Keystone Symposia, 2018. All rights reserved.

About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Visit Keystone Symposia at:

Visit Virtual Keystone Symposia at:

For more videos:

Follow us on Twitter:

Like us on Facebook:

Link to us on LinkedIn:

Outro music:
“Slider” by Blue Dot Sessions (

Continue Reading

Trending